
Sign up to save your podcasts
Or


In this riveting episode, we unveil Nvidia's game-changing $50 million investment in Recursion, the AI-driven drug discovery firm. Join us for an exploration of the transformative potential of this collaboration as it reshapes the landscape of pharmaceutical research and revolutionizes the healthcare industry. Discover how technology is driving innovation in drug discovery in this captivating discussion!
See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
By Jaeden Schafer and Conor Grennan4.6
140140 ratings
In this riveting episode, we unveil Nvidia's game-changing $50 million investment in Recursion, the AI-driven drug discovery firm. Join us for an exploration of the transformative potential of this collaboration as it reshapes the landscape of pharmaceutical research and revolutionizes the healthcare industry. Discover how technology is driving innovation in drug discovery in this captivating discussion!
See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

334 Listeners

152 Listeners

208 Listeners

110 Listeners

197 Listeners

154 Listeners

227 Listeners

608 Listeners

107 Listeners

54 Listeners

173 Listeners

55 Listeners

62 Listeners

62 Listeners

48 Listeners

24 Listeners